Welcome to the New Era in Immune Health
Restoring Immune Function for Chronic Inflammatory Disease
We’re changing the way the world treats inflammatory diseases.
Network Immunology is transforming the future of human health by developing therapies that modulate - rather than suppress - the immune system.
Our mission is to address the root causes of immune dysfunction while preserving the body’s natural defenses, delivering smarter, safer solutions for lasting relief in chronic inflammatory disease.
One platform. Human-first impact.
Built on a single breakthrough platform, our immune-modulating therapy is designed for human inflammatory disease - validated and accelerated through canine models that closely mirror human immune dysfunction.
This translational approach reduces development risk while enabling faster, more informed progress toward scalable human therapies.
Leaders in Immune Innovation
Our team brings together dedicated experts in clinical medicine, veterinary therapeutics, biotech commercialization, and immunology research. With deep experience translating science into scalable therapies, we are purpose-built to move immune-resetting innovation from lab to clinic.
Product Pipeline
First dogs, then humans
Why companion animals? Because immune dysfunction affects dogs just as it does people, and what works in dogs often works in humans.
NI-CAN-001: For canine allergies
Projected date: 2025*
Mode of application: Injectable (under the skin)
NI-CAN-002: For autoimmune disease in dogs
Projected date: 2026*
Mode of application: Injectable (under the skin)
NI-CAN-003: For colitis and digestive inflammation
Projected date: 2027*
Mode of application: Injectable (under the skin)
Looking towards the future
NI-HUM-001: A first-of-its-kind therapy for reducing human allergies
Mode of application: Injectable (under the skin)
Projected date: 2028*
NI-HUM-002: Designed for human autoimmune conditions
Projected date: 2028*
Mode of application: Injectable (under the skin)